600201 Stock Overview
Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary products in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Jinyu Bio-technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.91 |
| 52 Week High | CN¥11.59 |
| 52 Week Low | CN¥6.94 |
| Beta | 0.58 |
| 1 Month Change | 3.73% |
| 3 Month Change | 1.25% |
| 1 Year Change | -17.19% |
| 3 Year Change | -59.17% |
| 5 Year Change | -44.59% |
| Change since IPO | 687.67% |
Recent News & Updates
There's Reason For Concern Over Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) Price
Mar 21
Does This Valuation Of Jinyu Bio-technology Co., Ltd. (SHSE:600201) Imply Investors Are Overpaying?
Feb 28Shareholder Returns
| 600201 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 1.1% | 2.8% | 2.1% |
| 1Y | -17.2% | -24.0% | -14.2% |
Return vs Industry: 600201 exceeded the CN Biotechs industry which returned -24% over the past year.
Return vs Market: 600201 underperformed the CN Market which returned -14.2% over the past year.
Price Volatility
| 600201 volatility | |
|---|---|
| 600201 Average Weekly Movement | 5.5% |
| Biotechs Industry Average Movement | 7.9% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 600201 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600201's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 1,618 | Jing Zhang | www.jinyu.com.cn |
Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary products in China. Its product portfolio includes Jinyu Baoling, Yangzhou Youbang, and Liaoning Yikang animal vaccines for the prevention of foot, porcine, mycoplasma pneumoniae, porcine reproductive and respiratory syndrome, porcine pseudorabies, pathogenic avian influenza, brucellosis bacterial disease, bovine viral diarrhea and mucosal, infectious rhinotracheitis, and other domestic animal diseases. The company was founded in 1992 and is headquartered in Hohhot, China.
Jinyu Bio-technology Co., Ltd. Fundamentals Summary
| 600201 fundamental statistics | |
|---|---|
| Market cap | CN¥9.69b |
| Earnings (TTM) | CN¥288.91m |
| Revenue (TTM) | CN¥1.64b |
33.5x
P/E Ratio5.9x
P/S RatioIs 600201 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600201 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.64b |
| Cost of Revenue | CN¥668.56m |
| Gross Profit | CN¥970.70m |
| Other Expenses | CN¥681.79m |
| Earnings | CN¥288.91m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.27 |
| Gross Margin | 59.22% |
| Net Profit Margin | 17.62% |
| Debt/Equity Ratio | 0% |
How did 600201 perform over the long term?
See historical performance and comparison